Interesting stuff in Q1 MD&A and Interim Financial StatementIbex hasn't put them up yet, on their website. But you can get them off of Sedar-
https://www.sedar.com/search/search_form_pc_en.htm
fwiw, a couple things that I found kind of interesting-
1. 54% gross margin, which I think is pretty good
2. An uptick in Arthritis Assay inventory (after being flat for several quarters), may be indicating that they are anticipating increased sales of these assays...which would be most welcomed !
3. R&D expense is still incredibly low, at $7k - I seem to recall that they were talking about bring in a new R&D guy by q4 . But it doesn't look like that has happened during q1, with the Expense being that low.